- $9.43bn
- $8.88bn
- $642.82m
Brief: 10X Genomics & Nih Card To Create Comprehensive Single Cell Atlas Of The Human Brain
10x Genomics sues rival Curio over gene-sequencing technology
NanoString down after company withdraws annual forecast
U.S. RESEARCH ROUNDUP-Appian Corp, Eversource Energy, Victoria'S Secret & Co
Brief: Owkin Integrates 10X Genomics Spatial Omics And Single-Cell Technologies To The Mosaic Study
U.S. RESEARCH ROUNDUP- Booking Holdings, Eli Lilly, Markel Group
10X Genomics Inc reports results for the quarter ended in September - Earnings Summary
Brief: 10X Genomics Q3 Revenue USD 153.6 Million Vs. IBES Estimate USD 151.3 Million
10X Genomics Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: 10X Genomics Comments On Second Upc Preliminary Injunction Decision
Brief: 10X Wins Injunction From Unified Patent Court Banning Sales Of Nanostring's CosMx Products In Europe
10x Genomics defeats startup's attempt to end gene-analysis patent case (updated)
10x Genomics defeats startup's attempt to end gene-analysis patent case
Brief: European Unified Patent Court Heard Arguments From Nanostring Technologies And 10X Genomics In Germany
10X Genomics Inc reports results for the quarter ended in June - Earnings Summary
Brief: 10X Genomics Q2 Revenue USD 146.8 Million Vs. IBES Estimate USD 140 Million
10X Genomics Inc expected to post a loss of 40 cents a share - Earnings Preview
10x, Harvard must face antitrust claims in gene-analysis patent cases (updated)
10x, Harvard must face antitrust claims in gene-analysis patent cases